{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T19:28:22Z","timestamp":1768246102286,"version":"3.49.0"},"posted":{"date-parts":[[2025,5,7]]},"group-title":"In Review","reference-count":16,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,4,21]]},"abstract":"<title>Abstract<\/title>\n                <p>Background:\n Cardiac amyloidosis is an underrecognized etiology of heart failure with preserved ejection fraction (HFpEF), particularly in elderly patients. Light-chain (AL) amyloidosis, when associated with multiple myeloma, is highly aggressive and portends a poor prognosis, especially in advanced cardiac stages.\nCase Presentation:\n We report the case of a 79-year-old male with type 2 diabetes, hypertension, and a history of pacemaker implantation for complete atrioventricular block in the context of atrial fibrillation. He was admitted with progressive exertional dyspnea and an episode of syncope. Clinical examination revealed fine basal crackles and signs of decompensated heart failure. ECG demonstrated a paced rhythm. Echocardiography and cardiac MRI revealed concentric left ventricular hypertrophy with a sparkling myocardial texture, biatrial dilation, restrictive filling pattern, and diffuse subendocardial late gadolinium enhancement\u2014features highly suggestive of cardiac amyloidosis. Laboratory tests revealed anemia, renal dysfunction, elevated troponin and NT-proBNP, and a monoclonal IgG lambda spike. Bone marrow biopsy confirmed the diagnosis of multiple myeloma with plasma cell infiltration. Based on clinical and laboratory findings, the patient was classified as Mayo stage IIIB AL cardiac amyloidosis and ISS stage I multiple myeloma. He received bortezomib-cyclophosphamide-based chemotherapy and supportive care, but unfortunately died five months after diagnosis.\nDiscussion:\n This case highlights the importance of early recognition of cardiac amyloidosis in elderly patients with unexplained heart failure and monoclonal gammopathy. Cardiac MRI and serum free light chain analysis are critical tools in the diagnostic pathway. Despite advances in treatment, outcomes remain poor in advanced cardiac involvement. Early intervention may improve prognosis, underscoring the need for heightened clinical awareness.\nConclusion:\n Infiltrative cardiomyopathies like AL amyloidosis should be considered in elderly patients with heart failure and systemic red flags. Timely diagnosis and multidisciplinary management are essential but often insufficient in advanced stages.<\/p>","DOI":"10.21203\/rs.3.rs-6498469\/v1","type":"posted-content","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T05:06:53Z","timestamp":1746594413000},"source":"Crossref","is-referenced-by-count":0,"title":["Silent Progression: Cardiac Amyloidosis Unmasking IgG Lambda Myeloma in an Elderly Patient"],"prefix":"10.21203","author":[{"given":"soufiane","family":"touiti","sequence":"first","affiliation":[{"name":"Cardiac Catheterization Unit, Military Hospital Mohamed V"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriem","family":"Bouali","sequence":"additional","affiliation":[{"name":"Cardiac Catheterization Unit, Military Hospital Mohamed V"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loubna El","family":"Bahri","sequence":"additional","affiliation":[{"name":"Non invasive cardiac explorations , Military Hospital Mohamed V"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"lyasse","family":"Asfalou","sequence":"additional","affiliation":[{"name":"Non invasive cardiac explorations , Military Hospital Mohamed V"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zouhair","family":"Lakhal","sequence":"additional","affiliation":[{"name":"Cardiac Catheterization Unit, Military Hospital Mohamed V"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aatif","family":"Benyass","sequence":"additional","affiliation":[{"name":"Cardiac Catheterization Unit, Military Hospital Mohamed V"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","author":"Muchtar E","year":"2021","unstructured":"Muchtar E, Dispenzieri A, Magen H, et al. Systemic Amyloidosis from A (AA) to T (ATTR): A Review. J Intern Med. 2021;289(3):268\u2013292. 2021;"},{"key":"ref2","author":"Kyle RA","year":"1995","unstructured":"Kyle RA, Gertz MA. Primary Systemic Amyloidosis: Clinical and Laboratory Features in 474 Cases. Semin Hematol. 1995;32(1):45\u201359. 1995;"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111519","author":"Tana M","year":"2024","unstructured":"Tana M, Piccinini R, Moffa L, Tana C. Heart Failure with Preserved Ejection Fraction and Cardiac Amyloidosis in the Aging Heart. Int J Mol Sci. 2024;25(21):11519. Published 2024 Oct 26. doi:10.3390\/ijms252111519. 2024;"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"E45-E48","DOI":"10.1002\/ajh.25685","article-title":"Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes","volume":"95","author":"Staron A","year":"2020","unstructured":"Staron, A., Kataria, Y., Murray, D.L., Sloan, J.M. and Sanchorawala, V. Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes. Am J Hematol, 95: E45-E48. https:\/\/doi.org\/10.1002\/ajh.25685. 2020;","journal-title":"Am J Hematol"},{"key":"ref5","author":"Huan T","year":"2020","unstructured":"Huan T Nguyen, Chuyen T H Nguyen,. Cardiac amyloidosis mimicking acute coronary syndrome: a case report and literature review, European Heart Journal - Case Reports, Volume 4, Issue 6, December 2020,. 2020;"},{"key":"ref6","author":"Garcia-Pavia P","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021, 42:1554-68. 2021;"},{"key":"ref7","author":"Gertz MA","year":"2005","unstructured":"Gertz MA, Comenzo R, Falk RH, et al. Definition of Organ Involvement and Treatment Response in Immunoglobulin Light Chain Amyloidosis (AL): A Consensus Opinion from the 10th International Symposium on Amyloid and Amyloidosis. Am J Hematol. 2005;79(4):319\u2013328. 2005;"},{"key":"ref8","author":"Donnelly JP","year":"2017","unstructured":"Donnelly JP, Hanna M. Cardiac Amyloidosis: An Update on Diagnosis and Treatment. Cleve Clin J Med. 2017;84(12 Suppl 3):12\u201326. 2017;"},{"key":"ref9","author":"Fontana M","year":"2015","unstructured":"Fontana M, Pica S, Reant P, et al. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis. Circulation. 2015;132(16):1570\u20131579. 2015;"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.751293","author":"Razvi Y","year":"2021","unstructured":"Razvi Y, Patel RK, Fontana M, Gillmore JD. Cardiac Amyloidosis: A Review of Current Imaging Techniques. Front Cardiovasc Med. 2021;8:751293. Published 2021 Dec 10. doi:10.3389\/fcvm.2021.751293. 2021;"},{"key":"ref11","author":"Kumar S","year":"2012","unstructured":"Kumar S, Dispenzieri A, Lacy MQ, et al. Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements. J Clin Oncol. 2012;30(9):989\u2013995. 2012;"},{"key":"ref12","author":"Palladini G","year":"2020","unstructured":"Palladini G, Merlini G. Multiple myeloma and AL amyloidosis: Similarities and differences. Haematologica. 2020;105(3):562\u2013564. 2020;"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/life13071518","author":"R\u00edos-Tamayo R","year":"2023","unstructured":"R\u00edos-Tamayo R, Krsnik I, G\u00f3mez-Bueno M, Garcia-Pavia P, Segovia-Cubero J, Huerta A, Salas C, Silvestre R\u00c1, S\u00e1nchez A, Manso M, Delgado L, Lahuerta JJ, Mart\u00ednez-L\u00f3pez J, Duarte RF. AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor. Life (Basel). 2023;13(7):1518. doi: 10.3390\/life13071518. PMID: 37511893; PMCID: PMC10382070. 2023;"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S287922","author":"Xu J","year":"2021","unstructured":"Xu J, Wang M, Shen Y, et al. Effects of Amyloid Light-Chain Amyloidosis on Clinical Characteristics and Prognosis in Multiple Myeloma: A Single-Center Retrospective Study. Cancer Manag Res. 2021;13:1343\u20131356. Published 2021 Feb 11. doi:10.2147\/CMAR.S287922. 2021;"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101366","author":"Pour-Ghaz I","year":"2022","unstructured":"Pour-Ghaz I, Bath A, Kayali S, et al. A Review of Cardiac Amyloidosis: Presentation, Diagnosis, and Treatment. Curr Probl Cardiol. 2022;47(12):101366. doi:10.1016\/j.cpcardiol.2022.101366. 2022;"},{"key":"ref16","author":"Kastritis E","year":"2021","unstructured":"Kastritis E, Palladini G, Minnema MC, et al. Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis. N Engl J Med. 2021;385(1):46\u201358. 2021;"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6498469\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6498469\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:14:32Z","timestamp":1768234472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6498469\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":16,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6498469\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s43044-026-00715-w","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,5,7]]},"subtype":"preprint"}}